Publicaciones

  1. Rodriguez-Salas N, Dominguez G, Barderas R, Mendiola M, García-Albéniz X, Maurel J, Batlle JF. Clinical relevance of colorectal cancer molecular subtypes. Crit Rev Oncol Hematol. 2017;109:9-19.

    doi:10.1016/j.critrevonc.2016.11.007

  2. Pablo San Segundo-Acosta, María Garranzo-Asensio, Ana Montero-Calle, Carmen Oeo-Santos, Mayte Villalba, Ana Guzmán-Aránguez, Rodrigo Barderas. Protein Microarrays in Neurodegenerative Diseases. Current Proteomic Approaches Applied to Brain Function. Neuromethods. Springer. ISBN: 978-1-4939-7118-3. 2017.

    doi:10.1007/978-1-4939-7119-0_4

  3. Garranzo-Asensio M, Guzmán-Aránguez A, Povés C, Fernández-Aceñero MJ, Torrente-Rodríguez RM, Ruiz-Valdepeñas Montiel V, Domínguez G, Frutos LS, Rodríguez N, Villalba M, Pingarrón JM, Campuzano S, Barderas R. Toward Liquid Biopsy: Determination of the Humoral Immune Response in Cancer Patients Using HaloTag Fusion Protein-Modified Electrochemical Bioplatforms. Anal Chem. 2016;88(24):12339-12345.

    doi:10.1021/acs.analchem.6b03526

  4. Katchman BA, Barderas R, Alam R, Chowell D, Field MS, Esserman LJ, Wallstrom G, LaBaer J, Cramer DW, Hollingsworth MA, Anderson KS. Proteomic mapping of p53 immunogenicity in pancreatic, ovarian, and breast cancers. Proteomics Clin Appl. 2016 Jul;10(7):720-31.

    doi:10.1002/prca.201500096

  5. Villar-Vázquez R, Padilla G, Fernández-Aceñero MJ, Suárez A, Fuente E, Pastor C, Calero M, Barderas R & Casal JI. Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis. Proteomics. 2016;16(8):1280-90.

    doi:10.1002/pmic.201500413

  6. Eletxigerra U, Martínez-Perdiguero J, Barderas R, Pingarrón JM, Campuzano S, Merino S. Surface plasmon resonance immunosensor for ErbB2 breast cancer biomarker determination in human serum and raw cancer cell lysates. Anal Chim Acta. 2016 Jan 28;905:156-62.

    doi:10.1016/j.aca.2015.12.020

  7. Peltomaa R, López-Perolio I, Benito-Peña E & Barderas R, Moreno-Bondi MC. Application of bacteriophages in sensor development. Anal Bioanal Chem. 2016 Mar;408(7):1805-28.

    doi:10.1007/s00216-015-9087-2

  8. Ferrer-Mayorga G, Álvarez-Díaz S, Valle N, De Las Rivas J, Mendes M, Barderas R, Canals F, Tapia O, Casal JI, Lafarga M, Muñoz A. Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression. J Biol Chem. 2015;290(44):26533-48.

    doi:10.1074/jbc.M115.660175

  9. Peláez-García A, Barderas R, Mendes M, López-Lucendo M, Sanchez JC, García de Herreros A, Casal JI. Data from proteomic characterization of the role of Snail1 in murine mesenchymal stem cells and 3T3-L1 fibroblasts differentiation. Data Brief. 2015 Jul 31;4:606-13.

    doi:10.1016/j.dib.2015.07.027

  10. Peláez-García A, Barderas R, Batlle R, Viñas-Castells R, Bartolomé RA, Torres S, Mendes M, López-Lucendo M, Mazzolini R, Bonilla F, García de Herreros A, Casal JI. A proteomic analysis reveals that Snail regulates the expression of the nuclear orphan receptor Nuclear Receptor Subfamily 2 Group F Member 6 (Nr2f6) and interleukin 17 (IL-17) to inhibit adipocyte differentiation. Mol Cell Proteomics. 2015 Feb;14(2):303-15.

    doi:10.1074/mcp.M114.045328

  11. Mas S, Torres M, Garrido-Arandia M, Salamanca G, Castro L, Barral P, Purohit A, Pauli G, Rodríguez R, Batanero E, Barderas R & Villalba M. Ash pollen immunoproteomics: identification, immunologic characterization, and sequencing of 6 new allergens J Allergy Clin Immunol. 2014;133(3):923-6.e3.

    doi:10.1016/j.jaci.2013.10.061

  12. Barderas R, Villar-Vázquez R, Fernández-Aceñero MJ, Babel I, Peláez-García A, Torres S, Casal JI. Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep. 2013 Oct 15;3:2938.

    doi:10.1038/srep02938.

  13. Torres S, Bartolomé RA, Mendes M, Barderas R, Fernández-Aceñero MJ, Peláez-García A, Peña C, López-Lucendo M, Villar-Vázquez R, de Herreros AG, Bonilla F, Casal JI. Proteome profiling of cancer-associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res. 2013 Nov 1;19(21):6006-19.

    doi:10.1158/1078-0432.CCR-13-1130

  14. Peláez-García A & Barderas R, Torres S, Hernández-Varas P, Teixidó J, Bonilla F, de Herreros AG, Casal JI. FGFR4 role in epithelial-mesenchymal transition and its therapeutic value in colorectal cancer. PLoS One. 2013;8(5):e63695.

    doi:10.1371/journal.pone.0063695

  15. Bartolomé RA, Barderas R, Torres S, Fernández-Aceñero MJ, Mendes M, García-Foncillas J, López-Lucendo M, Casal JI. Cadherin-17 interacts with α2β1 integrin to regulate cell proliferation and adhesion in colorectal cancer cells causing liver metastasis. Oncogene. 2014;33(13):1658-69.

    doi:10.1038/onc.2013.117

  16. Batlle R, Alba-Castellón L, Loubat-Casanovas J, Armenteros E, Francí C, Stanisavljevic J, Barderas R, Martín- Caballero J, Bonilla F, Baulida J, Casal JI, Gridley T, García de Herreros A. Snail1 controls TGF-β responsiveness and differentiation of mesenchymal stem cells. Oncogene. 013;32(28):3381-9. Epub 2012 Aug 6.

    doi:10.1038/onc.2012.342

  17. Barderas R, Mendes M, Torres S, Bartolomé RA, López-Lucendo M, Villar-Vázquez R, Peláez-García A, Fuente E, Bonilla F, Casal JI. In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration, and invasion. Mol Cell Proteomics. 2013;12(6):1602-20.

    doi:10.1074/mcp.M112.022848

  18. Barderas R, Bartolomé RA, Fernández-Aceñero MJ, Torres S, Casal JI. High expression of IL-13 receptor α2 in colorectal cancer is associated with invasion, liver metastasis, and poor prognosis. Cancer Res. 2012 Jun 1;72(11):2780-90.

    doi:10.1158/0008-5472.CAN-11-4090

  19. Barderas R, Babel I, Díaz-Uriarte R, Moreno V, Suárez A, Bonilla F, Villar-Vázquez R, Capellá G, Casal JI. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor associated antigens obtained from protein and phage microarrays. J Proteomics. 2012;75(15):4647-55.

    doi:10.1016/j.jprot.2012.03.004